Purdue Pharma Consultant to Pay Nevada $45 Million in Opioid Settlement
Nevada says the money will help pay for costs stemming from the opioid epidemic.
Read moreNevada says the money will help pay for costs stemming from the opioid epidemic.
Read moreThe plan, filed late Monday night in U.S Bankruptcy Court in White Plains, N.Y., after months of negotiations, marks the company’s formal offer to settle more than 2,900 lawsuits from state and local governments, Native American tribes, hospitals and other entities.
Read moreBeverly Veres’ two sons are addicted to heroin but can’t get the help they need, with U.S. health services consumed by the coronavirus pandemic at a time when overdoses are surging.
Read moreA federal court in California ruled against a putative class of chronic pain patients who claimed Walgreens and Costco violate state law and federal discrimination statutes by interfering with their access to opioids.
Read moreGlobal consulting firm McKinsey & Co. will pay $573 million to settle claims that the aggressive marketing campaign it designed for pharmaceutical drugs intensified the national opioid crisis.
Read moreThe Biden administration hit a Central California pharmacist and his pharmacy with an unfair competition lawsuit Tuesday, claiming they dispensed hundreds of thousands of opioid pills based on prescriptions they had to have known were fake.
Read moreAccusing Walmart of adding fuel to the fire of America’s opioid crisis, the Justice Department filed a lawsuit Tuesday claiming the retail giant unlawfully dispensed controlled substances at its more than 5,000 pharmacies.
Read moreTwo of the owners of the company that makes OxyContin acknowledged to a congressional committee on Thursday that the powerful prescription painkiller has played a role in the national opioid crisis but stopped short of apologizing or admitting wrongdoing as they faced grilling during a rare appearance in a public forum.
Read moreTwo members of the Sackler family who own OxyContin maker Purdue Pharma agreed to appear this week before a congressional committee investigating the family and the company’s role in the national opioid addiction and overdose epidemic.
Read morePurdue Pharma pleaded guilty Tuesday to federal criminal charges related to the OxyContin manufacturer’s role in the nation’s deadly opioid crisis.
Read moreProposed settlements between the federal government and OxyContin maker Purdue Pharma and its owners cleared a major legal hurdle Tuesday when a bankruptcy judge said they could move ahead.
Read moreThe Third Circuit showed little sign Monday that it will stop a nonprofit from opening a so-called safe injection site where drug users can get high under medical supervision.
Read moreWalmart preemptively sued the federal government Thursday, claiming its pharmacists are being forced by federal guidance to not fulfill valid opioid prescriptions and risk lawsuits for interfering with doctor-patient relationships.
Read moreEven as the coronavirus outbreak and the Trump administration’s response to the pandemic have been a dominating theme in this year’s presidential race, Ohio, a battleground state in the presidential contest, is on track to have one of its deadliest years of opioid drug overdoses
Read moreThe $8.34 billion fine ranks as the largest penalty against a drugmaker, but Purdue Pharma can receive nearly $2 billion in credits through bankruptcy reorganization.
Read moreA federal judge on Thursday advanced a bellwether lawsuit seeking to hold dozens of prescription drug makers and distributors liable for the opioid crisis and problems it has caused in San Francisco.
Read more(CN) — The coronavirus pandemic has been front and center these past six months, but America is still in the midst
Read moreThe Sixth Circuit ruled Thursday against the use of a novel form of settlement class devised to pursue opioid manufacturers for their role in the U.S. opioid addiction crisis.
Read moreMexican authorities say seizures of the synthetic opioid fentanyl so far this year are 465% higher than in 2019, but progress against another big Mexican export to the U.S. market — methamphetamines — is slower.
Read moreThe Second Circuit reversed a ruling that had blocked the enforcement of part of New York’s Opioid Stewardship Act, which requires opioid manufacturers and distributors to collectively pay $100 million annually to support statewide programs that provide opioid treatment, recovery, prevention and education services.
Read more